This website is best viewed
using the horizontal display
on your tablet device.
This site is intended for U.S. Healthcare Professionals.
Go to Patient Website
Go to Patient Website
It is estimated that
HCM may affect
1 in 200 to
1 in 500 people in the general population2-4
It is estimated that
HCM may affect
1 in 200 to
1 in 500 people in the general population2-4
REFERENCES:
Naidu SS, ed. Hypertrophic Cardiomyopathy. London, Eng: Springer-Verlag;2015.
Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142(25):e533-e631.
Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995;92(4):785-789.
Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249-1254.
Back To Top
This website is best viewed
using the vertical display
on your mobile device.